IP Library › Granted Patent US 10,829,814
Granted Patent B2
US 10,829,814 · App. 14/742,027 · Granted Nov 10, 2020

Methods and compositions for single cell genomics

Inventors: Jian-Bing Fan (San Diego, CA); Kun Zhang (San Diego, CA)
Assignees: Illumina, Inc.; The Regents of the University of Caliofrnia
C12Q1/6874C12Q1/6841
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,829,814
App. No.
14/742,027
Filed
Jun 17, 2015
Granted
Nov 10, 2020
Kind
B2
Art Unit
1634
USPC
435/6.1
Abstract

Presented are methods and compositions for obtaining sequence information from one or more individual cells. The methods are useful for obtaining sequence information for a single nucleotide sequence, and for multiplex generation of sequence information from one or more individual cells.

Claims (16)

1. A method of providing sequence information regarding at least one target nucleic acid sequence in a plurality of nucleic acid molecules from an individual cell comprising:

(a) amplifying a plurality of nucleic acid molecules in situ within a cell, thereby generating a set of amplified nucleic acid molecules, wherein the set of amplified nucleic acid molecules comprise the at least one target nucleic acid sequence;

(b) for each amplified nucleic acid sequence of said set of amplified nucleic acid molecules, annealing in situ a padlock probe that is designed to anneal to the at least one target nucleic acid sequence, wherein the padlock probe comprises two sequence-specific capturing arms on the 5′ and 3′ end of the probe, wherein the capturing arms are ligatable when each are annealed to the target nucleic acid sequence, wherein the padlock probe further comprises at least a first decoder sequence and a second decoder sequence that do not anneal to said amplified nucleic acid molecules, and wherein the padlock probe can be identified based upon generating a code from decoding the at least first decoder sequence and the second decoder sequence by using sequential hybridization with fluorescently labeled decoder probes, and identifying the padlock probe by matching said code with a reference code that is assigned for each padlock probe, wherein each padlock probe that hybridizes to a different target nucleic acid sequence has a different reference code;

(c) hybridizing a first fluorescently labeled decoder probe to said first decoder sequence, wherein the first fluorescently labeled decoder probe that is not hybridized to said first decoder sequence is removed by washing;

(d) detecting a plurality of fluorescent signals indicative of said hybridizing of the first fluorescently labeled decoder probe to said first decoder sequence;

(e) de-hybridizing and removing the first fluorescently labeled decoder probe;

(f) hybridizing a second fluorescently labeled decoder probe to said second decoder sequence, wherein the second fluorescently labeled decoder probe that is not hybridized to said second decoder sequence is removed by washing, and wherein the second fluorescently labeled decoder probe is labeled with a fluor that absorbs light at a different wavelength than the fluor of the first fluorescently labeled decoder probe;

(g) detecting a plurality of fluorescent signals indicative of said hybridizing of the second fluorescently labeled decoder probe to said second decoder sequence, and

(h) determining the identity of the padlock probe based upon decoding the plurality of fluorescent signals generated from hybridization of the first fluorescently labeled decoder probe with the first decoder sequence of the padlock probe, and the plurality of fluorescent signals generated from hybridization of the second fluorescently labeled decoder probe to the second decoder sequence of the padlock probe, wherein identification of the padlock probe provides sequence information regarding the at least one target nucleic acid sequence in the plurality of nucleic acid molecules from an individual cell.

2. The method of claim 1 , wherein said amplifying a plurality of nucleic acid molecules in situ within a cell comprises rolling circle amplification.

3. The method of claim 1 , wherein said amplified nucleic acid molecules are immobilized within said cell.

4. The method of claim 1 , wherein said amplified nucleic acid molecules are amplified from cellular RNA.

5. The method of claim 4 , further comprising cDNA synthesis using said cellular RNA.

6. The method of claim 1 , wherein said amplified nucleic acid molecules comprise DNA.

7. The method of claim 1 , wherein said nucleic acid molecules comprise a disease-causing mutation.

8. The method of claim 7 , wherein said disease-causing mutation comprises a base substitution.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2018
From: FAN, JIAN-BING
To: ILLUMINA, INC.
Reel/Frame 046373/0386 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2018
From: ZHANG, KUN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 046373/0698 →
Continuity (2)
Provisional Application 62014538 · Jun 19, 2014
Related Publication 20150368704A1 · Dec 24, 2015
Cited By (52)
US 12,188,085 US 12,188,087 US 12,195,798 US 12,209,237 US 12,209,273 US 12,215,379 US 12,227,796 US 12,234,507 US 12,258,624 US 12,270,071 US 12,270,074 US 12,275,984 US 12,286,671 US 12,291,746 US 12,291,747 US 12,297,499 US 12,319,956 US 12,325,877 US 12,338,493 US 12,359,251 US 12,359,253 US 12,360,105 US 12,365,944 US 12,391,984 US 12,400,733 US 12,435,364 US 12,460,250 US 12,467,081 US 12,473,546 US 12,497,651 US 12,497,653 US 12,509,717 US 12,509,723 US 12,510,744 US 12,516,369 US 12,522,819 US 12,522,820 US 12,529,096 US 12,553,079 US 12,559,791 US 12,646,340 US 12,655,474 US 12,662,699 US 12,674,196 US 12,687,494 US 12,692,484 US 12,703,879 US 12,709,771 US 12,716,092 US 12,718,518 US 12,730,295 US 12,735,738